A first step towards a global nomogram to predict disease progression for men on active surveillance.
Van Hemelrijck M, Ji X, Helleman J, Roobol MJ, Nieboer D, Bangma C, Frydenberg M, Rannikko A, Lee LS, Gnanapragasam V, Kattan MW; Movember Foundation’s Global Action Plan Prostate Cancer Active Surveillance (GAP3) Consortium.
Van Hemelrijck M, et al. Among authors: nieboer d.
Transl Androl Urol. 2021 Mar;10(3):1102-1109. doi: 10.21037/tau-20-1082.
Transl Androl Urol. 2021.
PMID: 33850745
Free PMC article.